Login / Signup

Contribution of Clostridium difficile infection to the development of lower gastrointestinal adverse events during autologous stem cell transplantation.

Senu ApewokinJ A GoodwinJ Y LeeS W EricksonN SanathkumarV R RajD ZhouK D McKelveyO StephensE A Coleman
Published in: Transplant infectious disease : an official journal of the Transplantation Society (2015)
CDI is a prominent factor in the development of LGAE in patients undergoing autologous SCT.
Keyphrases
  • stem cell transplantation
  • patients undergoing
  • high dose
  • bone marrow
  • cell therapy
  • platelet rich plasma
  • mesenchymal stem cells